Italy Cardiovascular Devices Market: By Device Type (Diagnostic and Monitoring Devices, Therapeutic and Surgical Devices), By Application (Cardiac Arrhythmia, Heart Failure, and Others), By End User (Hospitals, Specialty Clinics, and Others) and Country

Italy cardiovascular devices market size was valued at US$ 58.2 million in 2023 and is projected to reach a value of US$ 76.1 million by 2030, at a CAGR of 3.9% from 2024-2030.

The prevalence of cardiovascular diseases, advancement in medical technology combined with an increase in the aging population with greater healthcare needs is promoting the market. However, the markets face several challenges including the high price of advanced devices making products unavailable, and stringent regulatory requirements. Further, demand for home healthcare solutions and expansion of the distribution network will provide companies with an opportunity to improve access to innovative devices.

Key Players

Key players in the Italy cardiovascular devices market include Medtronic, Boston Scientific, Abbott Laboratories, Edwards Lifesciences, Siemens Healthineers, Biotronik, Terumo Corporation, St. Jude Medical, and Philips Healthcare.

Key Takeaways

• Based on the device type, therapeutic and surgical devices segment holds a 42.3% market share
• Based on the application, cardiac arrhythmia segment holds a 31.8% market share
• Based on the end-use, hospitals segment holds a 36.2% market share

Facts & Figures

• In April 2024: The Italian government allocated €10 million for the development of innovative cardiovascular technologies aimed at improving patient outcomes
• May 2024: A survey showed that 55% of cardiologists in Italy prefer using remote monitoring devices for managing patients with chronic heart conditions
• July 2024: The market for cardiovascular diagnostic devices is projected to grow by 12% annually, driven by increasing awareness and preventive healthcare initiatives.

Key Developments

• In March 2024, Terumo launched a new range of vascular access devices tailored for cardiac procedures in Italy.
• In May 2024, St. Jude Medical unveiled an innovative cardiac rhythm management device designed for better patient outcomes in arrhythmia treatment.
• In August 2024, AtriCure received regulatory approval for its new surgical ablation device for the treatment of atrial fibrillation, expanding its offerings in the Italian market.

Italy Cardiovascular Devices Market Segmentation

By Device Type: In the market, the Therapeutic and Surgical Devices segment usually is the one with the largest market share. This segment includes a wide array of products such as stents, pacemakers, and heart valves, all of which are very important in treating cardiovascular diseases. The reasons behind its growth are various as the high demand for interventions and procedures related to cardiovascular diseases makes this segment grow. The Diagnostic and Monitoring Devices segment usually follows the trend, as monitoring technologies evolve in improving patient care, but do not reach the level of surgical interventions.

By Application: In the cardiovascular devices market in Italy, Cardiac Arrhythmia is generally the largest in terms of market share. The high incidence of arrhythmia coupled with the growing adoption of treatment devices such as pacemakers and ICDs describes this phenomenon. Heart Failure is also a critical segment since, over time, growth in monitoring and therapeutic devices specifically aimed at treating heart failure is beginning to gain traction. The Others category, which could also include applications for coronary artery disease and peripheral vascular conditions, represents a smaller but still important portion of the market.

By End-use: Traditionally, the hospitals segment has dominated the market. Given that hospitals are primarily sites for the conduct of cardiovascular procedures and surgeries, they have naturally fuelled demand for a broad range of diagnostic and therapeutic devices. The Specialty Clinics segment is another major segment, particularly for outpatient procedures and targeted cardiovascular care, which are rapidly gaining popularity. Others: This will include home healthcare and rehabilitation centers. They may hold a smaller market share but are on an uptrend because of the growing demand for remote monitoring and home care-based solutions. Altogether, hospitals would be the largest end-use sector, given the critical nature of cardiovascular care.